Edgewise Therapeutics, Inc.
EWTX
$13.45
$0.423.22%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 47.67% | 70.02% | 65.12% | 62.45% | -9.53% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -38.25% | -16.10% | 8.78% | 60.19% | 70.31% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 45.41% | 67.64% | 63.86% | 62.41% | -8.40% |
|
|||||
Total Current Assets | 45.41% | 67.64% | 63.86% | 62.41% | -8.40% |
Net Property, Plant & Equipment | -12.75% | -10.73% | -9.58% | -3.18% | 28.82% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -24.71% | -43.90% | -37.47% | -- | 38.65% |
Total Assets | 43.17% | 64.21% | 60.80% | 59.87% | -7.37% |
|
|||||
Total Accounts Payable | 38.61% | 6.22% | 79.87% | 21.88% | -34.07% |
Total Accrued Expenses | 46.91% | 22.07% | -3.69% | 10.57% | 19.19% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.63% | 6.55% | 13.30% | 23.46% | 61.18% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 42.27% | 16.03% | 19.28% | 14.83% | 1.12% |
|
|||||
Total Current Liabilities | 42.27% | 16.03% | 19.28% | 14.83% | 1.12% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -15.63% | -25.03% | -16.21% | -11.97% | 16.68% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 30.16% | 7.01% | 10.45% | 7.43% | 4.02% |
|
|||||
Common Stock & APIC | 48.60% | 63.56% | 62.97% | 62.95% | 14.38% |
Retained Earnings | -54.67% | -57.91% | -61.34% | -63.22% | -69.27% |
Treasury Stock & Other | 324.24% | 347.88% | -92.69% | -243.03% | 107.31% |
Total Common Equity | 44.03% | 68.33% | 63.90% | 62.68% | -8.04% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 44.03% | 68.33% | 63.90% | 62.68% | -8.04% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 44.03% | 68.33% | 63.90% | 62.68% | -8.04% |
|